Sysmex to absorb subsidiary to boost efficiency

Sysmex Corporation resolved on November 21, 2025, to absorb Sysmex Medica, a company specializing in assembling units of diagnostic instruments. This merger aims to optimize the equipment production process within the Sysmex Group, enhancing efficiency and productivity. The effective date for this absorption-type merger is scheduled for April 1, 2026.

As Sysmex Medica is a wholly owned subsidiary, the merger will not involve the issuance of new shares or allotment of money. The company confirmed that there will be no changes to Sysmex Corporation's name, location, business description, share capital, or fiscal year-end after the merger.

Sysmex Corporation reported consolidated net sales of JPY 508,643 million and total assets of JPY 665,268 million as of March 31, 2025. Sysmex Medica, as of the same date, had share capital of JPY 20 million and 400 issued shares, with Sysmex Corporation holding 100%. The impact on Sysmex Corporation's consolidated financial results is expected to be minor.